Chief Executive Officer

Jeff is a dynamic BioPharma Executive and Scientific Leader who is adept at orchestrating the progression of therapeutic products from conceptualization to clinical development. His distinguished career is characterized by exceptional leadership, where he has led teams in pioneering programs across a spectrum of disease indications.

Chief Scientific Officer

Marcio has over 25 years of experience in pharmaceutical drug discovery and biotech R&D. He has contributed to the discovery and development of 15 oncology clinical candidates and 12 IND submissions. He completed his Postdoc education at the NCI and has over forty publications and nine granted patents. He has experience vetting companies in his past role as Executive Director of Biotechnology Research at Eli Lilly.

Chief Medical Officer

Mayukh is an accomplished oncology clinical and translational development expert with extensive experience in driving innovations within the biotech and startup environment. With a proven track record in advancing over 20 investigational oncology assets from first-in-human to Phase III registration trials, Dr. Das possesses a deep understanding of the entire product lifecycle, from preclinical stages to commercial launches.

Director of Research

Kevin is an accomplished biomedical researcher, specialized in immune-based approaches to combat cancers and infectious diseases. His expertise ranges from understanding disease mechanisms, contributing to vaccine design and development, antibody discovery and engineering, and next-generation sequencing.

Director of Operations

Brad is a seasoned Director of Operations with over a decade of experience where he has masterfully integrated technology with biology. At Irazu, he spearheaded the transformation from a small analytical lab to a comprehensive microbial manufacturing suite, analytical lab, and cell culture lab. With an unwavering commitment to scaling up operations while maintaining stringent control measures, Brad is driven by his passion for delivering safe and effective medicines to patients in need.